Canada’s health care system currently stifles domestic innovation by prioritizing lowest-bidder procurement over economic value to the entire system, experts told Research Money's 25th annual conference. They argue that shifting to a value-based model that rewards both clinical and economic outcomes is essential to fix this fragmented and risk-adverse system and retain homegrown medical technology startups.